This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
ISRG da Vinci 5 Gets European Nod: Will it Boost the Stock's Prospect?
by Indrajit Bandyopadhyay
ISRG's da Vinci 5 wins CE mark, unlocking Europe's surgical robotics market as U.S. adoption shows strong early traction.
Intuitive Surgical's Fifth Generation da Vinci System Receives CE Mark
by Zacks Equity Research
ISRG secures CE mark for its da Vinci 5 system, unlocking European access to its most advanced surgical platform yet.
Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
Can ISRG Maintain Robotics Edge Amid Rising Rivalry & Budget Strain?
by Indrajit Bandyopadhyay
ISRG posted strong Q1 growth, but rising rivals and tighter hospital budgets test its robotics dominance and pricing power.
Intuitive Surgical, Inc. (ISRG) Rises Higher Than Market: Key Facts
by Zacks Equity Research
In the closing of the recent trading day, Intuitive Surgical, Inc. (ISRG) stood at $534.38, denoting a +2.44% move from the preceding trading day.
Wall Street Analysts See Intuitive Surgical (ISRG) as a Buy: Should You Invest?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Intuitive Surgical (ISRG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Walgreens Q3 Earnings Top Estimates, Stock Up, Gross Margin Declines
by Zacks Equity Research
WBA tops Q3 earnings and sales estimates and lifts shares, but the gross margin contracts, and guidance is withdrawn.
Is ISRG's Procedure Growth Enough to Offset Margin Pressures in 2025?
by Indrajit Bandyopadhyay
Intuitive Surgical raises 2025 procedure outlook after strong Q1 growth, but rising costs and tariff pressure weigh on margins.
Intuitive Surgical, Inc. (ISRG) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $515.09, marking a +1.12% move from the previous day.
Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock
by Zacks Equity Research
Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
ISRG vs BSX: Which Medical Device Stock Has More Room to Run?
by Indrajit Bandyopadhyay
Boston Scientific offers steady growth with broader exposure, while Intuitive Surgical leads in robotics but faces margin and tariff headwinds.
Intuitive Surgical, Inc. (ISRG) Suffers a Larger Drop Than the General Market: Key Insights
by Zacks Equity Research
In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $512.11, marking a -1.34% move from the previous day.
ISRG's Minimally Invasive Ecosystem Powers Surgical Precision
by Indrajit Bandyopadhyay
ISRG's robotic platforms, led by da Vinci and Ion, are transforming surgical precision and driving strong stock gains.
Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?
by Zacks Equity Research
Sector ETF report for IHI
Intuitive Surgical, Inc. (ISRG) Suffers a Larger Drop Than the General Market: Key Insights
by Zacks Equity Research
In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $522.41, marking a -1.36% move from the previous day.
ISRG Margin Outlook Dips on Tariffs, Demand Signals Stay Strong
by Harshit Gupta
Intuitive Surgical trims margin outlook on tariff headwinds, but strong procedure growth and financial resilience bolster its long-term case.
Should You Invest in Intuitive Surgical (ISRG) Based on Bullish Wall Street Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Intuitive Surgical (ISRG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Is Trending Stock Intuitive Surgical, Inc. (ISRG) a Buy Now?
by Zacks Equity Research
Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Intuitive Surgical Stock Gains 12.7% QTD: Is it Still a Buy Now?
by Indrajit Bandyopadhyay
ISRG's shares seem to recover after declining more than 30% from its all-time high. Is it the right time to invest?
Intuitive Surgical's da Vinci 5: Gaining Precision, Power and Potential
by Indrajit Bandyopadhyay
ISRG's da Vinci 5 is gaining momentum with key innovations like Force Feedback and strong Q1 placements boosting adoption.
Intuitive Surgical, Inc. (ISRG) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $557.95, moving +1.11% from the previous trading session.
Tandem Diabetes Care (TNDM) Up 6.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Tandem Diabetes Care (TNDM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights Berkshire Hathaway, AbbVie, Intuitive Surgical, Hamilton Beach Brands and AXIL Brands
by Zacks Equity Research
Zacks highlights strong showings from ABBV, ISRG, HBB and AXIL, while BRK.B gains on insurance growth and capital strength despite headwinds.
Intuitive Surgical, Inc. (ISRG) Laps the Stock Market: Here's Why
by Zacks Equity Research
In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $555.75, marking a +0.6% move from the previous day.
Top Research Reports for Berkshire Hathaway, AbbVie & Intuitive Surgical
by Mark Vickery
Berkshire Hathaway, AbbVie and Intuitive Surgical beat estimates as analysts highlight growth drivers, headwinds and strategic moves in new reports.